Showing results (1761-1770 of 2,646) with videos related to

Sort By:
Pageof 265
Journal of Biomolecular NMR|August 4, 2014
A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligandQi Sun, Jason Phan, Anders R Friberg, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2013
Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsOren Zusman, Tomer Avni, Leonard Leibovici, et al.
Heart (British Cardiac Society)|February 6, 2025
Dysglycaemia and incident aortic stenosis: a cohort studyViktor Lind, Pia Lundman, Leif Friberg, et al.
JTCVS Open|July 17, 2024
Postoperative atrial fibrillation is associated with long-term morbidity and mortality in older adults: Analysis from the SWEDEHEART RegistryMathias Lilja, Richard Leaback, Jonas Banefelt, et al.
Frontiers in Reproductive Health|September 6, 2023
Development of in vitro methods to model the impact of vaginal lactobacilli on Staphylococcus aureus biofilm formation on menstrual cups as well as validation of recommended cleaning directionsMaria Friberg, Kara Woeller, Vighter Iberi, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2023
Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictionsAnna Olsson, Christer Malmberg, Chenyan Zhao, et al.
BMC Cancer|April 18, 2015
Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusionGini F Fleming, Philip Schumm, Greg Friberg, et al.
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2018
Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?Maria Goul Andersen, Anders Thorsted, Merete Storgaard, et al.
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
Pharmacokinetic/pharmacodynamic modelling in oncological drug developmentMats O Karlsson, Therese Anehall, Lena E Friberg, et al.
Pageof 265